Cargando…
Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction
Fibrates, peroxisome proliferator-activated receptor-α agonists, are potent lipid-modifying drugs. Their main effects are reduction of triglycerides and increase in high-density lipoprotein levels. Several randomized controlled trials have not demonstrated their benefits on cardiovascular risk reduc...
Autores principales: | Kim, Nam Hoon, Kim, Sin Gon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188966/ https://www.ncbi.nlm.nih.gov/pubmed/32347023 http://dx.doi.org/10.4093/dmj.2020.0001 |
Ejemplares similares
-
Triglyceride Level and Cardiovascular Risk Reduction Using Pemafibrate Compared with Fibrates
por: Masuda, Daisaku
Publicado: (2023) -
Lagrangian Fibrations
por: Huybrechts, D., et al.
Publicado: (2022) -
Fibrates consistently lower risk of cardiovascular events across high-risk groups
por: Aalbers, J
Publicado: (2010) -
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
por: Tenenbaum, Alexander, et al.
Publicado: (2012) -
Update on the use of fibrates: focus on bezafibrate
por: Goldenberg, Ilan, et al.
Publicado: (2008)